Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anti-retroviral therapy of human immunodeficiency virus infection: current strategies and challenges for the future.

× No keyword cloud information.

12 in total

1. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.

Authors: J P Moore; Q J Sattentau; R Wyatt; J Sodroski
Journal: J Virol Date: 1994-01 Impact factor: 5.103

Review 2. Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription.

Authors: E J Arts; M A Wainberg
Journal: Antimicrob Agents Chemother Date: 1996-03 Impact factor: 5.191

3. Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro.

Authors: A R Bender; H von Briesen; J Kreuter; I B Duncan; H Rübsamen-Waigmann
Journal: Antimicrob Agents Chemother Date: 1996-06 Impact factor: 5.191

Review 4. Vertical human immunodeficiency virus-1 infection: involvement of the central nervous system and treatment.

Authors: C Exhenry; D Nadal
Journal: Eur J Pediatr Date: 1996-10 Impact factor: 3.183

Review 5. Pathogenesis of human immunodeficiency virus infection.

Authors: J A Levy
Journal: Microbiol Rev Date: 1993-03

6. Inhibitors of human immunodeficiency virus integrase.

Authors: M R Fesen; K W Kohn; F Leteurtre; Y Pommier
Journal: Proc Natl Acad Sci U S A Date: 1993-03-15 Impact factor: 11.205

7. Preclinical evaluation of antiviral activity and toxicity of Abbott A77003, an inhibitor of the human immunodeficiency virus type 1 protease.

Authors: J J Kort; J A Bilello; G Bauer; G L Drusano
Journal: Antimicrob Agents Chemother Date: 1993-01 Impact factor: 5.191

8. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.

Authors: L Dubrovsky; P Ulrich; G J Nuovo; K R Manogue; A Cerami; M Bukrinsky
Journal: Mol Med Date: 1995-01 Impact factor: 6.354

9. Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro.

Authors: J J Eron; V A Johnson; D P Merrill; T C Chou; M S Hirsch
Journal: Antimicrob Agents Chemother Date: 1992-07 Impact factor: 5.191

10. Pharmacokinetics of R 82913 in AIDS patients: a phase I dose-finding study of oral administration compared with intravenous infusion.

Authors: S De Wit; P Hermans; B Sommereijns; E O'Doherty; R Westenborghs; V van de Velde; G F Cauwenbergh; N Clumeck
Journal: Antimicrob Agents Chemother Date: 1992-12 Impact factor: 5.191